Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib Extension in Kidney Transplant
NCT00263328Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2005
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tofacitinib in kidney transplant rejection, sponsored by Pfizer. Started Dec 2005; status: completed.
02
Drugs
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00263328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00263328.